Beauty Lab and Laser v. Fowler
A court ruling in Beauty Lab and Laser v. Fowler clarifies that medical spas must operate under direct physician supervision for all medical procedures, including injectables and laser treatments. This decision impacts scope of practice and medical director requirements.
Aforeworn detected this change in the Med-Spa & Aesthetics Clinics space on July 8, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. All medical spas and aesthetics clinics offering injectables, laser, or other medical cosmetic services, especially nurse-owned and multi-location practices. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediate; regulatory enforcement may follow. Consult legal counsel within 30 days.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Med-Spa & Aesthetics Clinics continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
The court affirmed that medical spa procedures constitute the practice of medicine, requiring direct supervision by a licensed physician. This may invalidate existing supervision arrangements that rely on remote or delegated oversight.
Who it affects
All medical spas and aesthetics clinics offering injectables, laser, or other medical cosmetic services, especially nurse-owned and multi-location practices.
What you must do
Review and revise supervision agreements to ensure on-site physician presence during all medical procedures. Update protocols for medical director involvement.
Deadline
Immediate; regulatory enforcement may follow. Consult legal counsel within 30 days.
Source: https://www.courtlistener.com/opinion/10761846/beauty-lab-and-laser-v-fowler/
Never miss a change like this again
Aforeworn watches Med-Spa & Aesthetics Clinics around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Med-Spa & Aesthetics Clinics
- Haugen / Norvell v. Oregon Health Authority
- Smith v. Upper Chesapeake Medical Ctr.
- Regulatory Considerations for Microneedling Products; Guidance for Industry and Food and Drug Administration Staff; Availability
- Hazardous Drugs: NIOSH List of Hazardous Drugs in Healthcare Settings, 2024 and Final Reevaluation Determinations for Liraglutide and Pertuzumab